Berliner Boersenzeitung - Pharma giants to pay $590 mn to US Native Americans over opioids

EUR -
AED 3.846458
AFN 71.211176
ALL 97.412843
AMD 406.811894
ANG 1.887241
AOA 956.640935
ARS 1051.428592
AUD 1.608171
AWG 1.887622
AZN 1.787721
BAM 1.94682
BBD 2.114156
BDT 125.138011
BGN 1.955509
BHD 0.394704
BIF 3034.333258
BMD 1.047225
BND 1.407209
BOB 7.235625
BRL 6.090347
BSD 1.047075
BTN 88.4754
BWP 14.296058
BYN 3.427092
BYR 20525.602023
BZD 2.110863
CAD 1.463847
CDF 3005.534618
CHF 0.928583
CLF 0.03695
CLP 1019.567969
CNY 7.576459
CNH 7.597437
COP 4597.630131
CRC 532.296452
CUC 1.047225
CUP 27.751452
CVE 110.613091
CZK 25.354142
DJF 186.112546
DKK 7.458821
DOP 63.25565
DZD 139.901282
EGP 52.012714
ERN 15.708369
ETB 129.23088
FJD 2.379611
FKP 0.826592
GBP 0.831973
GEL 2.853676
GGP 0.826592
GHS 16.598349
GIP 0.826592
GMD 74.352935
GNF 9037.548191
GTQ 8.083713
GYD 219.089433
HKD 8.150638
HNL 26.363899
HRK 7.470124
HTG 137.485836
HUF 411.088281
IDR 16675.428446
ILS 3.890063
IMP 0.826592
INR 88.480582
IQD 1372.387829
IRR 44093.391567
ISK 146.108348
JEP 0.826592
JMD 166.302915
JOD 0.742584
JPY 161.458939
KES 135.614106
KGS 90.595555
KHR 4241.259434
KMF 491.829597
KPW 942.501737
KRW 1466.554465
KWD 0.322158
KYD 0.872675
KZT 519.294876
LAK 22997.052059
LBP 93778.962407
LKR 304.684618
LRD 188.762185
LSL 18.965252
LTL 3.092182
LVL 0.633456
LYD 5.115689
MAD 10.486854
MDL 19.069043
MGA 4891.586326
MKD 61.525564
MMK 3401.344628
MNT 3558.469111
MOP 8.394618
MRU 41.799981
MUR 48.593488
MVR 16.179757
MWK 1817.981712
MXN 21.385321
MYR 4.675828
MZN 66.925952
NAD 18.964918
NGN 1774.186923
NIO 38.527419
NOK 11.597222
NPR 141.561038
NZD 1.78822
OMR 0.403194
PAB 1.04717
PEN 3.974207
PGK 4.216653
PHP 61.815578
PKR 291.021899
PLN 4.344987
PYG 8218.776313
QAR 3.812683
RON 4.977038
RSD 116.989628
RUB 106.083365
RWF 1435.744917
SAR 3.931627
SBD 8.750118
SCR 14.091129
SDG 629.903184
SEK 11.589368
SGD 1.409667
SHP 0.826592
SLE 23.651533
SLL 21959.781063
SOS 598.485238
SRD 37.077012
STD 21675.434737
SVC 9.162736
SYP 2631.183058
SZL 18.975788
THB 36.383713
TJS 11.152657
TMT 3.675758
TND 3.301902
TOP 2.452702
TRY 36.169354
TTD 7.108213
TWD 34.046633
TZS 2777.615603
UAH 43.232448
UGX 3869.006119
USD 1.047225
UYU 44.622895
UZS 13488.252609
VES 48.454165
VND 26623.067216
VUV 124.328608
WST 2.923423
XAF 652.945238
XAG 0.034027
XAU 0.000392
XCD 2.830177
XDR 0.798815
XOF 651.373441
XPF 119.331742
YER 261.711912
ZAR 18.966175
ZMK 9426.275251
ZMW 28.876803
ZWL 337.205892
  • RBGPF

    -0.5000

    59.69

    -0.84%

  • CMSC

    0.1200

    24.64

    +0.49%

  • BCE

    -0.3200

    26.68

    -1.2%

  • NGG

    -0.1700

    63.1

    -0.27%

  • BTI

    -0.1000

    36.98

    -0.27%

  • AZN

    1.0600

    64.26

    +1.65%

  • BCC

    2.9500

    140.36

    +2.1%

  • SCS

    -0.0300

    13.04

    -0.23%

  • RIO

    0.1800

    62.57

    +0.29%

  • RELX

    0.6500

    45.76

    +1.42%

  • GSK

    0.3500

    33.7

    +1.04%

  • RYCEF

    0.1800

    6.79

    +2.65%

  • CMSD

    0.1850

    24.445

    +0.76%

  • VOD

    -0.1000

    8.84

    -1.13%

  • BP

    0.4400

    29.52

    +1.49%

  • JRI

    0.0000

    13.23

    0%

Pharma giants to pay $590 mn to US Native Americans over opioids
Pharma giants to pay $590 mn to US Native Americans over opioids

Pharma giants to pay $590 mn to US Native Americans over opioids

A group of pharmaceutical companies and distributors agreed to pay $590 million to settle lawsuits connected to opioid addiction among Native American tribes, according to a US court filing released Tuesday.

Text size:

The agreement is the latest amid a deluge of litigation spawned by the US opioid crisis, which has claimed more than 500,000 lives over the last 20 years and ensnared some of the largest firms in the world of American medicine.

The companies involved in the latest agreement include Johnson & Johnson and McKesson, according to a filing in an Ohio federal court by a committee of plaintiffs in the case.

Native Americans have "suffered some of the worst consequences of the opioid epidemic of any population in the United States," according to the filing from the Plaintiffs' Tribal Leadership Committee, which cited per-capita death rates compared with other ethnic groups.

"The burden of paying these increased costs has diverted scarce funds from other needs and has imposed severe financial burdens on the tribal plaintiffs."

Johnson & Johnson, McKesson and the other two companies in the accord -- AmerisourceBergen and Cardinal Health -- have previously agreed to a $26 billion global settlement on opioid cases.

J&J said Tuesday the $150 million it agreed to pay in the Native American case has been deducted from what it owes in the global settlement.

"This settlement is not an admission of any liability or wrongdoing and the company will continue to defend against any litigation that the final agreement does not resolve," the company said.

It was unclear if the other companies would take what they owe under the latest agreement from the global settlement.

- 'Measure of justice' -

Robins Kaplan, a law firm negotiating on the behalf of the plaintiffs, said in a statement the agreement must still be approved by the Native American tribes, which are pursuing other claims regarding opioids.

"This initial settlement for tribes in the national opioid litigation is a crucial first step in delivering some measure of justice to the tribes and reservation communities across the United States that have been ground zero for the opioid epidemic," Tara Sutton, an attorney at the firm who negotiated on behalf of the Native Americans.

Douglas Yankton, chairman of the North Dakota-based Spirit Lake Nation, said the money from the settlement would "help fund crucial, on-reservation, culturally appropriate opioid treatment services."

All tribes recognized by the US government, 574 in all, will be able to participate in the agreement, even if they have not filed lawsuits.

The settlement is separate from a prior agreement that resulted in $75 million in payments to the Cherokee Nation from three distribution companies, including McKesson.

Many of the lawsuits regarding the opioid crisis have centered on Purdue Pharma, the manufacturer of OxyContin, a highly addictive prescription painkiller blamed for causing a spike in addiction.

A judge in December overturned the company's bankruptcy plan because it provided some immunity for the owners of the company in exchange for a $4.5 billion payout to victims of the opioid crisis.

The litigation wave has also swamped pharmacies owned by Walmart, Walgreens and CVS, which a jury found in November bear responsibility for the opioid crisis in two counties in Ohio.

(O.Joost--BBZ)